Clinical Research Directory
Browse clinical research sites, groups, and studies.
RECOMMEND Platform Trial
Sponsor: Australian and New Zealand Intensive Care Research Centre
Summary
The goal of this platform trial is to determine the efficacy, safety and cost-effectiveness of various interventions in patients with acute cardiorespiratory failure requiring extracorporeal membrane oxygenation (ECMO) The main question the platform trial aims to address is to determine the effect of a range of interventions on survival, organ support and resource utilisation to day 28 for hospitalised patients receiving ECMO. Researchers will compare various interventions within multiple platform trial domains to see if the interventions have effects on survival, organ support and resource utilisation for the patient cohort. Participants will be enrolled in accordance with the platform trial's domain structure to answer the research questions.
Official title: Generating New Evidence to Reduce Major Complications to Improve the Safety and Efficacy of ECMO in Severe Cardiac and Respiratory Failure (RECOMMEND)
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2025-09
Completion Date
2029-06
Last Updated
2025-05-31
Healthy Volunteers
Yes
Conditions
Interventions
Liberal RBC Transfusion
Liberal transfusion trigger group (patient receives RBC transfusion if Hb \<90g/L).
Restrictive RBC Transfusion
Restrictive transfusion trigger group (patient receives RBC transfusion if Hb \<70g/L).
Locations (3)
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
St. Vincent's Hospital Sydney
Sydney, New South Wales, Australia
The Alfred Hospital
Melbourne, Victoria, Australia